PL2125878T3 - Krótkie, aktywne biologicznie peptydy do komórkowych i immunologicznych modulacji - Google Patents

Krótkie, aktywne biologicznie peptydy do komórkowych i immunologicznych modulacji

Info

Publication number
PL2125878T3
PL2125878T3 PL07868047T PL07868047T PL2125878T3 PL 2125878 T3 PL2125878 T3 PL 2125878T3 PL 07868047 T PL07868047 T PL 07868047T PL 07868047 T PL07868047 T PL 07868047T PL 2125878 T3 PL2125878 T3 PL 2125878T3
Authority
PL
Poland
Prior art keywords
cellular
active peptides
immunological modulation
short bio
bio
Prior art date
Application number
PL07868047T
Other languages
English (en)
Inventor
Scott M Harris
Lijuan Zhang
Timothy J Falla
Original Assignee
Helix Biomedix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helix Biomedix Inc filed Critical Helix Biomedix Inc
Publication of PL2125878T3 publication Critical patent/PL2125878T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/18Antioxidants, e.g. antiradicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1024Tetrapeptides with the first amino acid being heterocyclic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Insects & Arthropods (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
PL07868047T 2007-01-05 2007-12-27 Krótkie, aktywne biologicznie peptydy do komórkowych i immunologicznych modulacji PL2125878T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US87884907P 2007-01-05 2007-01-05
PCT/US2007/026368 WO2008085494A1 (en) 2007-01-05 2007-12-27 Short bio-active peptides for cellular and immunological modulation
EP07868047A EP2125878B1 (en) 2007-01-05 2007-12-27 Short bio-active peptides for cellular and immunological modulation

Publications (1)

Publication Number Publication Date
PL2125878T3 true PL2125878T3 (pl) 2013-08-30

Family

ID=39345537

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07868047T PL2125878T3 (pl) 2007-01-05 2007-12-27 Krótkie, aktywne biologicznie peptydy do komórkowych i immunologicznych modulacji

Country Status (16)

Country Link
US (1) US7696174B2 (pl)
EP (1) EP2125878B1 (pl)
JP (1) JP5342455B2 (pl)
CN (1) CN101679495B (pl)
AU (1) AU2007342353B2 (pl)
BR (1) BRPI0720874C1 (pl)
CA (1) CA2673791C (pl)
CY (1) CY1114002T1 (pl)
DK (1) DK2125878T3 (pl)
ES (1) ES2404669T3 (pl)
HK (1) HK1137463A1 (pl)
MX (1) MX2009007248A (pl)
PL (1) PL2125878T3 (pl)
RU (1) RU2458069C2 (pl)
SI (1) SI2125878T1 (pl)
WO (1) WO2008085494A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2065029B1 (en) * 2007-11-30 2013-04-17 Evonik Goldschmidt GmbH Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K
IT1393348B1 (it) * 2009-03-13 2012-04-20 Prevete Peptide per rigenerare tessuti lesionati
DE102009046780A1 (de) * 2009-11-17 2011-05-19 Evonik Goldschmidt Gmbh Tetrapeptide zur Aufhellung der Haut
ES2633437T3 (es) * 2013-02-14 2017-09-21 Helix Biomedix, Inc. Péptidos bioactivos cortos para promover la cicatrización de heridas
RU2687151C2 (ru) 2013-06-14 2019-05-07 Хеликс Биомедикс Инк. Тетрапептиды, полученные из с-х-с-хемокинов человека, подходящие для лечения различных состояний кожи
CN112759653B (zh) * 2019-11-06 2023-06-23 珠海联邦制药股份有限公司 一种pkek融合蛋白及其制备方法与应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6360939A (ja) * 1986-08-29 1988-03-17 Shin Etsu Chem Co Ltd 抗菌物質
US5861478A (en) 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
DE3854476T2 (de) 1987-07-06 1996-04-04 Univ Louisiana State Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden.
EP0365655B1 (en) 1988-04-21 1994-09-21 Uab Research Foundation Bioelastomeric materials suitable for the protection of wound repair sites from the occurrence of adhesions
HU218090B (hu) * 1989-01-31 2000-05-28 Stuart A. Aaronson Eljárás hámsejtekre specifikus növekedési faktor és az ezt kódoló DNS, az ez ellen termelődött antitestek valamint a növekedési faktort vagy az antitestet tartalmazó gyógyászati készítmények előállítására
AU5433190A (en) * 1989-04-10 1990-11-16 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
US5561107A (en) 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
US5763576A (en) 1995-10-06 1998-06-09 Georgia Tech Research Corp. Tetrapeptide α-ketoamides
EP0858808B1 (en) 1997-01-17 2003-04-02 Johnson & Johnson Medical Ltd. Peptides for use in wound treatment
US6492326B1 (en) 1999-04-19 2002-12-10 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
CA2276542C (en) 1999-06-28 2013-07-30 Vladislav I. Deigin Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide
KR100385293B1 (ko) * 2000-05-13 2003-05-23 주식회사 리젠 바이오텍 βig-h3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법
GB0029777D0 (en) 2000-12-06 2001-01-17 Regen Therapeutics Plc Peptides
JP4310107B2 (ja) * 2001-03-28 2009-08-05 ヘリックス バイオメディックス,インコーポレイテッド 生物活性を有する短ペプチド及び該ペプチドの使用方法
US6875744B2 (en) * 2001-03-28 2005-04-05 Helix Biomedix, Inc. Short bioactive peptides
US7041506B2 (en) 2001-11-19 2006-05-09 Becton Dickinson And Company Peptides promoting cell adherence, growth and secretion
EP1534308A4 (en) 2001-11-28 2007-03-14 Becton Dickinson Co PEPTIDES WITH INHIBITORY ACTION OF GROWTH
US20040009911A1 (en) 2002-01-31 2004-01-15 Irm, Llc Hepsin substrates and prodrugs
EP1504033A2 (en) 2002-05-03 2005-02-09 Millenium Biologix Inc. Connective tissue stimulating peptides
US7541440B2 (en) 2002-09-30 2009-06-02 Immunomedics, Inc. Chimeric, human and humanized anti-granulocyte antibodies and methods of use
WO2005048968A1 (en) 2003-11-17 2005-06-02 Sederma Compositions containing mixtures of tetrapeptides and tripeptides
DE202004012807U1 (de) 2004-08-13 2004-10-21 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen mit DNA-Reparaturenzymen und Oligopeptiden
DE102004050563A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Kosmetische und der dermatologische Zusammensetzungen mit Wirkstoffen für einen verbesserten Hautkomfort
DE102005000868A1 (de) 2004-10-15 2006-04-20 Henkel Kgaa Zusammensetzungen mit Inhibitoren der Prostaglandin- und/oder Leukotrien-Synthese in Kombination mit Stimulatoren der Freisetzung kutaner Neuromediatoren
DE102004055541A1 (de) 2004-11-17 2006-05-18 Henkel Kgaa Kosmetische und dermatologische Zusammensetzungen zur Behandlung reifer Haut
US20060046271A1 (en) 2004-09-02 2006-03-02 Vanderbilt University Assessment of cancer susceptibility to molecular targeted therapy by use of recombinant peptides
US20070224150A1 (en) 2005-03-24 2007-09-27 Yongji Chung Growth factor for hair and skin treatment
FR2884418B1 (fr) 2005-04-15 2008-11-21 Soc Extraction Principes Actif Utilisation d'un peptide comme principe actif amincissant
AU2006266609C1 (en) 2005-07-05 2011-10-27 Biotempt B.V. Treatment of tumors
DE102005063062A1 (de) 2005-12-29 2007-07-05 Henkel Kgaa Synergistische Proteinhydrolysat-Kombinationen zur Behandlung reifer Haut
US7807625B2 (en) 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition

Also Published As

Publication number Publication date
HK1137463A1 (en) 2010-07-30
US20080206160A1 (en) 2008-08-28
EP2125878B1 (en) 2013-02-20
WO2008085494A1 (en) 2008-07-17
AU2007342353A1 (en) 2008-07-17
CA2673791C (en) 2014-11-25
RU2458069C2 (ru) 2012-08-10
SI2125878T1 (sl) 2013-06-28
EP2125878A1 (en) 2009-12-02
US7696174B2 (en) 2010-04-13
JP2010515679A (ja) 2010-05-13
JP5342455B2 (ja) 2013-11-13
ES2404669T3 (es) 2013-05-28
DK2125878T3 (da) 2013-05-27
BRPI0720874A2 (pt) 2014-03-04
BRPI0720874B1 (pt) 2018-11-21
CY1114002T1 (el) 2016-07-27
CN101679495B (zh) 2013-07-17
AU2007342353B2 (en) 2012-06-28
RU2009129950A (ru) 2011-02-10
BRPI0720874C1 (pt) 2021-05-25
MX2009007248A (es) 2009-08-17
CA2673791A1 (en) 2008-07-17
CN101679495A (zh) 2010-03-24

Similar Documents

Publication Publication Date Title
HK1220706A1 (zh) 特異性結合蛋白及其用途
HRP20160819T1 (hr) Proteini koji vežu heterodimere i njihove uporabe
EP2069401A4 (en) MULTISPECIENT EPITOP BINDING PROTEINS AND THEIR USE
IL232008A (en) Protein isolate heterodimer alpha-4-in-cell-7-specific antigen-binding and various aspects thereof
EP2654792A4 (en) HALF IMMUNOGLOBULIN BINDING PROTEINS AND USES THEREOF
EP2381952A4 (en) SPARC BINDING PEPTIDES AND USES THEREOF
ZA201004133B (en) Antigen binding proteins
IL200012A0 (en) Anti-robo4 antibodies and uses therefor
GB0812120D0 (en) Antigen binding polypeptides
ZA201002160B (en) Human gm-csf antigen binding proteins
EP2481754A4 (en) SPECIFIC BINDING PROTEINS AND USES THEREOF
EP2142572A4 (en) TGFP CAP PEPTIDE AND APPLICATIONS THEREOF
IL203221A (en) Bioactive peptides and antibodies
GB0712670D0 (en) Isolated peptides and uses thereof
IL232394A0 (en) Peptides and epitopes against p2x7
HK1137463A1 (en) Short bio-active peptides for cellular and immunological modulation
IL211040A (en) Melanoma antigen peptide and uses
EP2285827A4 (en) PEPTIDES AND ITS USE
EP2244725A4 (en) NOVEL PEPTIDES AND PROTEIN AND USE THEREOF
GB0722399D0 (en) MHC binding peptides and their uses
AU2007901644A0 (en) Novel Telomerase Peptide and Antibody
GB0710813D0 (en) Peptides and uses thereof
AU3053P (en) Stuart Glycine max
GB0816561D0 (en) Peptides and uses thereof
GB0903746D0 (en) Novel conjugated proteins and peptides